KiraGen was selected as one of seven recipients of Nomic Bio's inaugural Omni 1000 Proteomics Grant.
The award provides access to high-dimensional protein profiling that can measure how engineered CAR-T cells respond to complex suppressive conditions. These richer datasets will support KiraGen's efforts to connect specific engineering choices with cell state, function, and durability.
The grant expands KiraGen's experimental toolkit as it builds an evidence base for multiplex suppression resistance. Read Nomic Bio's grant announcement.